Form 4 for ACM AECOM
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-15 · accession 0001415889-22-012774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-19 | 2022-12-16 | ACM | Rudd Troy | CEO, Dir | F - Tax | $82.77 | -42.3K | 322.5K | -12% | -$3.50M |
| DM | 2022-12-19 | 2022-12-16 | ACM | Rudd Troy | CEO, Dir | S - Sale+OE | $82.51 | -139.3K | 198.0K | -41% | -$11.49M |
| DM | 2022-12-19 | 2022-12-16 | ACM | Rudd Troy | CEO, Dir | M - OptEx | $31.77 | +129.4K | 188.9K | +217% | +$4.11M |
| D | 2022-12-19 | 2022-12-16 | ACM | Rudd Troy | CEO, Dir | A - Grant | $0.00 | +69.7K | 258.6K | +37% | $0 |
| DM | 2022-12-19 | 2022-12-16 | ACM | Rudd Troy | CEO, Dir | M - OptEx | — | -129.4K | 159.3K | -45% | — |
| D | 2022-12-19 | 2022-12-15 | ACM | Rudd Troy | CEO, Dir | A - Grant | $0.00 | +36.8K | 36.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | F | D | 42,268 | $82.77 | 322,545 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-16 | S | D | 14,776 | $83.17 | 183,237 | D | — | — | (F6) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.92 to $83.50 the majority of which were sold to satisfy the option exercise price and related taxes. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range noted in this footnote. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2022. |
| 3 | Common | Common Stock | 2022-12-16 | M | A | 106,196 | $38.72 | 364,813 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-16 | A | A | 69,672 | $0.00 | 258,617 | D | — | — | (F2) Represents shares acquired pursuant to AECOM's Performance Earnings Program under the 2016 Stock Incentive Plan. |
| 5 | Common | Common Stock | 2022-12-16 | M | A | 23,224 | $0.00 | 188,945 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. These restricted stock units were granted on December 16, 2019, and vested in full on December 16, 2022. The Form 4 filed on December 17, 2019, reported a grant date of December 15, 2019, in error. |
| 6 | Common | Common Stock | 2022-12-16 | S | D | 124,532 | $82.43 | 198,013 | D | — | — | (F5) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.92 to $82.91 the majority of which were sold to satisfy the option exercise price and related taxes. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range noted in this footnote. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2022. |
| 7 | Derivative | Restricted Stock Units | 2022-12-16 | M | D | 23,224 | — | 0 | D | — · — to — | 23,224 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. These restricted stock units were granted on December 16, 2019, and vested in full on December 16, 2022. The Form 4 filed on December 17, 2019, reported a grant date of December 15, 2019, in error. |
| 8 | Derivative | Employee Stock Option | 2022-12-16 | M | D | 106,196 | — | 159,291 | D | $38.72 · — to 2027-08-15 | 106,196 Common Stock | (F3) Represents the exercise of a stock option that was exercisable in tranches subject to (A) Mr. Rudd's continued employment with the Issuer through the first, second, third, fourth and fifth anniversaries of the 8/15/2020 option grant date, and (B) the volume-weighted average prices of AECOM's common stock on the New York Stock Exchange during any consecutive 20 trading day period exceeding certain price hurdles. The exercise of the stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2022. |
| 9 | Derivative | Restricted Stock Units | 2022-12-15 | A | A | 36,812 | $0.00 | 36,812 | D | — · — to — | 36,812 Common Stock | (F7) Represents annual grant of restricted stock units. Each restricted stock unit represents a contingent right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2020 Stock Incentive Plan. The restricted stock units vest in full on December 15, 2025, subject to continued service through the vesting date. |